TY - JOUR AU - Ricardi, Umberto AU - Levra, Niccolò Giaj AU - Badellino, Serena AU - Alongi, Filippo PY - 2017 TI - Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer JF - Journal of Thoracic Disease; Vol 9, No 8 (August 28, 2017): Journal of Thoracic Disease Y2 - 2017 KW - N2 - Oligometastatic non-small cell lung cancer (NSCLC), presenting with one to five synchronous or metachronous metastatic lesions, has recently been considered a distinct disease state (1). In this setting, three different clinical conditions can be identified: (I) de novo oligometastatic—patients with a synchronous diagnosis of primary and metastatic lesions naive from oncological treatments; (II) oligorecurrent—patients with a controlled primary tumor after loco-regional treatment but with new and limited metastatic sites; (III) oligoprogressive—patients with a limited metastatic progression during systemic therapy (one or few sites), but with a control of the primary tumor and most of metastatic disease (2). UR - https://jtd.amegroups.org/article/view/15034